Posted by Michael Wonder on 22 Jan 2018
EMA publishes agenda for 22-25 January CHMP meeting
22 January 2018 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Emicizumab
- Enclomifene citrate
- Ertugliflozin
- Ertugliflozin with metformin hydrochloride
- Ertugliflozin with sitagliptin phosphate monohydrate
- Human herpes virus 3
- Insulin glargine
- Velmanase alfa
